Closing care gaps through scalable, data-driven CRC innovation
Watch the webinar
Watch "Closing the CRC Screening Gap: Streamline Workflows & Improve Outcomes" to learn how forward-thinking organizations like Privia Health are harnessing digital health technology to boost CRC screening rates and enhance patient care.
Hosted by the American Medical Group Association (AMGA) and Exact Sciences.
The power of partnership
Privia Health, one of the largest physician enablement organizations in the United States, collaborated with Exact Sciences and Amalgam Rx to launch a scalable, tech-enabled colorectal cancer (CRC) screening initiative across its network.
The program leveraged electronic health record (EHR) automation, patient outreach, and Cologuard® test integration to boost access and reduce clinician burden.
84%
42k+
From a population health standpoint, providing Cologuard tests is really moving the needle in the right way and helping to improve screening rates for colorectal cancer
Innovation in action
Key components of the program included:
- Adopting a Cologuard®-first approach for average-risk patients 45 and older, positioning it as the primary noninvasive screening option to reduce barriers to CRC screening.
- Collaborating with Exact Sciences and Amalgam Rx to automate CRC workflows in athenaClinicals®, enabling automatic bulk Cologuard test ordering, results delivery, and patient tracking.
- Using a clinical decision support (CDS) platform tool to identify eligible patients, trigger personalized email and text outreach, and automate standing test orders for non-responders.

Clinical studies